drugset / Trial / NCT00706589

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

NCT00706589

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in children and adolescents aged 6\~18 years with chronic tic disorders or Tourette's disorder

Timeline

Start
2008-10
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified Oral